Hemoglobin enhances the binding of bacterial endotoxin to human endothelial cells

Thrombosis and Haemostasis

Volumn 76, Issue 2, 1996, Pages 258-262

  Roth, Robert I ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b SAN FRANCISCO VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; BINDING PROTEIN; ENDOTOXIN; HEMOGLOBIN; HUMAN SERUM ALBUMIN; IMMUNOGLOBULIN G; PROCOAGULANT; THROMBOPLASTIN;

ARTICLE; CELL AGGREGATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; ISOTOPE LABELING; PRIORITY JOURNAL; UMBILICAL VEIN;

EID: 0029842387     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0038-1650565     Document Type: Article

References (16)

1. Moore KL, Andreoli SP, Esmon NL, Esmon CT, Bang NU. Endotoxin enhances tissue factor and suppresses thrombomodulin expression of human vascular endothelium in vitro. J Clin Invest 1987; 79: 124-30.
2. Colucci M, Balconi G, Lorenzet R, Pietra A, Locati D, Donati MB, Semeraro N. Cultured human endothelial cells generate tissue factor in response to endotoxin. J Clin Invest 1983; 71: 1893-6.
3. Roth RI. Hemoglobin enhances the production of tissue factor by endothelial cells in response to bacterial endotoxin. Blood 1994; 83: 2860-5.
4. Kaca W, Roth RI, Levin J. Hemoglobin, a newly recognized lipopolysaccharide (LPS)-binding protein that enhances LPS biological activity. J Biol Chem 1994; 269: 25078-84.
5. Kaca W, Roth RI, Ziolkowski A, Levin J. Human hemoglobin increases the biological activity of bacterial lipopolysaccharides in activation of Limulus amebocyte lysate and stimulation of tissue factor production by endothelial cells. J Endotoxin Research 1994; 1: 243-52.
6. Roth RI, Levin J, Chapman KW, Schmeizl M, Rickles FR. Production of modified crosslinked cell-free hemoglobin for human use: the role of quantitative determination of endotoxin contamination. Transfusion 1993; 33: 919-24.
7. White CT, Murray AJ, Smith DJ, Greene JR, Bolin RB. Synergistic toxicity of endotoxin and hemoglobin. J Lab Clin Med 1986; 108: 132-7.
8. Winslow RM. Blood substitutes - minireview. In: The Red Cell: Seventh Ann Arbor Conference. Brewer GJ, ed. Liss, New York, NY 1989; pp 305-23.
9. Fratantoni JC (Center for Biologics Evaluation and Research). Points to consider in the safety evaluation of hemoglobin-based oxygen carriers. Transfusion 1991; 31: 369-71.
10. Wright SD. Multiple receptors for endotoxin. Curr Opin Immunol 1991; 3: 83-90.
11. Tobias PS, Ulevitch RJ. Lipopolysaccharide-binding protein and CD14 in the lipopolysaccharide-dependent activation of cells. Chest 1994; 105: 48S-50S.
12. Osnes LTN, Westvik AB, Ovstebo R, Joo G-B, Okkenhaug C, Kierulf P. Lipopolysaccharide activation of human monocytes mediated by CD14 results in a coordinated synthesis of tissue factor, TNF-α and IL-6. J Endotoxin Res 1995; 2: 27-35.
13. Wright SD, Ramos RA, Tobias PS, Ulevitch RJ, Mathison JC. CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science 1990; 249: 1431-3.
14. Winslow RM, Chapman KW. Pilot-scale preparation of hemoglobin solutions. Meth Enzymol 1994; 231: 3-16.
15. Levin J, Bang FB. Clottable protein in Limulus: its localization and kinetics of its coagulation by endotoxin. Thromb Diath Haemorrh 1968; 19: 186-97.
16. Pugin J, Schurer-Maly C-C, Leturcq D, Moriarty A, Ulevitch RJ, Tobias PS. Lipopolysaccharide activation of human endothelial and epithelial cells is mediated by lipopolysaccharide-binding protein and soluble CD14. Proc Natl Acad Sci 1993; 90: 2744-8.